Company: PACB
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001299130-25-000156
Chunk: 7

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 1
Chunk 7
---
ITEM 1.  FINANCIAL STATEMENTS

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.CONDENSED CONSOLIDATED BALANCE SHEETS(Unaudited)

(In thousands, except par value)June 30,2025December 31,2024AssetsCurrent assets Cash and cash equivalents $54,803 $55,370 Investments 259,932 334,561 Accounts receivable, net32,257 27,524 Inventory, net53,839 58,755 Prepaid expenses and other current assets 12,266 18,781 Short-term restricted cash300 690 Total current assets 413,397 495,681 Property and equipment, net 23,102 30,505 Operating lease right-of-use assets, net 43,504 16,091 Long-term restricted cash1,532 1,532 Intangible assets, net17,163 389,572 Goodwill317,761 317,761 Other long-term assets 9,011 9,305 Total assets $825,470 $1,260,447 Liabilities and Stockholders’ Equity Current liabilitiesAccounts payable $15,055 $16,590 Accrued expenses 26,541 22,595 Deferred revenue, current 14,863 13,864 Operating lease liabilities, current703 10,026 Other liabilities, current 2,592 3,224 Total current liabilities 59,754 66,299 Deferred revenue, non-current 5,709 5,900 Contingent consideration liability, non-current— 18,700 Operating lease liabilities, non-current 52,082 14,914 Convertible senior notes, net, non-current646,436 647,494 Other liabilities, non-current — 546 Total liabilities 763,981 753,853 Commitments and contingencies Stockholders’ equityPreferred stock, $0.001 par value:Authorized 50,000 shares; No shares issued or outstanding — — Common stock, $0.001 par value:Authorized 1,000,000 shares; issued and outstanding 300,350 and 294,418 shares at June 30, 2025 and December 31, 2024, respectively 300 294 Additional paid-in capital 2,677,853 2,654,804 Accumulated other